Deccan Health Care (BSE 542248)₹12.09−1.23%Healthcare Service Provider
In the Jun 2026 quarter (consolidated), Deccan Health Care reported sales of ₹22 Cr, down 0.4% from Jun 2025, and net profit of ₹0.28 Cr, up 21.7% year on year. For the year to Mar 2026, sales were ₹81.65 Cr and net profit ₹2.50 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.11 | 15.27 | 15.92 | 15.00 | 18.76 | 20.35 | 20.67 | 22.08 | 21.32 | 17.33 | 20.92 | 22.00 |
| Expenses | 16.17 | 14.13 | 15.33 | 14.20 | 17.74 | 19.86 | 20.16 | 21.44 | 19.72 | 15.70 | 20.12 | 21.21 |
| Operating Profit | 1.03 | 1.22 | 0.66 | 0.86 | 1.10 | 0.58 | 0.60 | 0.74 | 1.70 | 1.72 | 0.88 | 0.89 |
| OPM % | 6.0% | 8.0% | 4.2% | 5.7% | 5.9% | 2.9% | 2.9% | 3.4% | 7.9% | 9.9% | 4.2% | 4.1% |
| Other Income | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.04 |
| Interest | 0.00 | 0.03 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.15 | 0.03 | 0.13 | 0.15 |
| Depreciation | 0.33 | 0.41 | 0.37 | 0.37 | 0.38 | 0.38 | 0.37 | 0.42 | 0.34 | 0.36 | 0.39 | 0.40 |
| Profit before tax | 0.71 | 0.78 | 0.29 | 0.48 | 0.70 | 0.19 | 0.22 | 0.32 | 1.21 | 1.33 | 0.36 | 0.37 |
| Tax % | 24.9% | 32.9% | 60.0% | 26.5% | 25.3% | 24.9% | 47.8% | 30.2% | 25.4% | 25.3% | 8.0% | 23.6% |
| Net Profit | 0.55 | 0.52 | 0.14 | 0.35 | 0.52 | 0.15 | 0.11 | 0.23 | 0.90 | 0.99 | 0.34 | 0.28 |
| EPS (Rs) | 0.31 | 0.25 | 0.05 | 0.17 | 0.24 | 0.05 | 0.04 | 0.09 | 0.36 | 0.39 | 0.12 | 0.11 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 42.09 | 33.64 | 33.04 | 44.83 | 59.56 | 74.76 | 81.65 | 81.57 |
| Expenses | 30.63 | 31.81 | 27.57 | 43.14 | 56.07 | 72.00 | 76.91 | 76.75 |
| Operating Profit | 11.62 | 2.03 | 5.62 | 1.95 | 3.75 | 3.13 | 5.07 | 5.19 |
| OPM % | 27.6% | 6.0% | 16.9% | 4.3% | 6.2% | 4.2% | 6.2% | 6.4% |
| Other Income | 0.07 | 0.07 | −3.45 | 0.03 | 0.02 | 0.02 | 0.00 | 0.04 |
| Interest | 0.17 | 0.10 | 0.14 | 0.10 | 0.08 | 0.06 | 0.36 | 0.46 |
| Depreciation | 1.43 | 1.48 | 1.48 | 1.44 | 1.48 | 1.46 | 1.47 | 1.49 |
| Profit before tax | 10.11 | 0.51 | 0.54 | 0.43 | 2.20 | 1.62 | 3.26 | 3.27 |
| Tax % | 0.4% | 24.9% | 39.9% | 31.8% | 33.0% | 28.8% | 23.8% | — |
| Exceptional items | 0.00 | 0.00 | −1.99 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 10.08 | 0.38 | 0.31 | 0.30 | 1.50 | 1.15 | 2.50 | 2.51 |
| EPS (Rs) | 6.40 | 0.24 | 0.19 | 0.17 | 0.72 | 0.49 | 1.00 | 0.98 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 15.76 | 15.74 | 15.74 | 17.05 | 20.43 | 23.46 | 24.79 |
| Reserves | 60.54 | 60.83 | 61.14 | 64.40 | 76.49 | 82.83 | 85.30 |
| Borrowings | 0.87 | 1.02 | 1.24 | 1.60 | 1.90 | 1.14 | 3.95 |
| Other Liabilities | 15.96 | 14.68 | 12.51 | 13.69 | 9.28 | 17.46 | 34.86 |
| Total Liabilities | 93.13 | 92.27 | 90.63 | 96.74 | 108 | 125 | 149 |
| Fixed Assets | 21.22 | 19.85 | 18.52 | 16.83 | 15.68 | 14.35 | 14.99 |
| CWIP | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 38.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 33.86 | 72.36 | 72.11 | 79.91 | 92.42 | 111 | 134 |
| Inventories | 0.00 | 45.16 | 46.16 | 47.17 | 46.16 | 43.17 | 47.17 |
| Trade receivables | 20.94 | 11.95 | 12.95 | 11.95 | 9.97 | 12.96 | 16.93 |
| Cash & equivalents | 2.99 | 3.01 | 3.01 | 0.99 | 2.99 | 3.99 | 1.99 |
| Total Assets | 93.13 | 92.27 | 90.63 | 96.74 | 108 | 125 | 149 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 2.69 | 0.23 | −0.58 | −6.78 | −12.58 | −6.45 | −3.63 |
| Cash from investing activity | −1.95 | −0.08 | −0.06 | 0.28 | −0.31 | −0.15 | −2.26 |
| Cash from financing activity | −1.76 | −0.36 | 0.06 | 5.24 | 14.00 | 7.50 | 3.95 |
| Net cash flow | −1.04 | −0.23 | −0.57 | −1.24 | 1.20 | 0.96 | −1.92 |
| Capex | 1.82 | 0.10 | 0.12 | 0.00 | 0.32 | 0.15 | 2.58 |
| Free cash flow | 0.88 | 0.07 | −0.64 | −6.52 | −12.88 | −6.58 | −5.87 |
| CFO / OP % | 23.0% | 18.1% | −6.0% | −334.0% | −311.0% | −204.0% | −70.9% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 178 | 135 | 141 | 97 | 60 | 61 | 76 |
| Inventory days | 0 | 890 | 1,182 | 683 | 444 | 326 | 339 |
| Days payable | — | 112 | 148 | 123 | 42 | 69 | 143 |
| Cash conversion cycle | 179 | 914 | 1,177 | 659 | 465 | 320 | 274 |
| Working capital days | 421 | 545 | 602 | 507 | 476 | 422 | 418 |
| ROCE % | — | 0.8% | 5.6% | 0.7% | 2.5% | 1.6% | 3.3% |
For the Jun 2026 quarter, Deccan Health Care reported sales of ₹22 Cr, down 0.4% year on year and net profit of ₹0.28 Cr, up 21.7% year on year. The operating margin was 4.1%.
Deccan Health Care's sales for the year to Mar 2026 were ₹81.65 Cr; over the last twelve months they were ₹81.57 Cr.
Net profit for the year to Mar 2026 was ₹2.50 Cr, and ₹2.51 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.98.
Deccan Health Care reported borrowings of ₹3.95 Cr at Mar 2026, against cash and equivalents of ₹1.99 Cr.
Cash from operations was −₹3.63 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.87 Cr.